Novo Nordisk’s research center in Seattle, Washington, is the
epicenter of the company’s R&D activities in the US. Teams are
part of a global organization, partnering with colleagues across
various international research centers. The team in Seattle is focused
on early discovery projects within the diabetes and obesity areas.
Scientists apply cutting edge technologies to bring molecules to
market. Right now, that means identifying protein and stem-cell based
therapies for obesity, diabetes, and other chronic diseases, as well
as research on the next generation of medical devices.
In the Community
We strive to make a difference in Seattle through support for local organizations and partnerships with the Seattle biotech and academic communities, and efforts focused on environmental awareness and health. We place emphasis on alternative means of transportation such as bicycling. Our company has received multiple recognitions and awards from organizations such as the Puget Sound Business Journal and the League of American Bicyclists for being a ‘bicycle-friendly’ business. We also have recycling and composting programs, aligning with the city of Seattle’s initiatives for a cleaner environment.